We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Congress should eliminate copays for insulin rather than focus on the life-saving biologics’ list price, an executive with one of the nation’s largest drugmakers said Wednesday. Read More
House representatives on both sides of the aisle expressed support for a new drug pricing bill during a Ways and Means Committee markup on Tuesday, calling it a good first step. Read More
Pharmacy benefit managers took their turn on the drug pricing hot seat Tuesday as Senators grilled five executives about their role in a system that both parties agree is out of control. Read More